- Tolerance of the anti-EGFR therapy2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Rechallenge with anti-EGFR therapy2023 | Third Faculty of Medicine
- Anti-EGFR therapy in colorectal carcinoma2017 | Publication without faculty affiliation
- Anti-EGFR treatment of colorectal cancer2021 | Publication without faculty affiliation
- Options and rationale for reinstituting anti-EGFR therapy in pretreated RAS wild-type advanced colorectal carcinomas2023 | Publication without faculty affiliation
- Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers2021 | Publication without faculty affiliation
- KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Long-term effect of panitumumab therapy in a patient with primarily generalized colorectal cancer - case report2021 | Publication without faculty affiliation
- Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma2011 | First Faculty of Medicine
- Adjuvantní léčba anti-EGFR tyrosinkinázovými inhibitory u resekovaného NSCLC a studie ADAURA – komentář2023 | First Faculty of Medicine
- Anti-EGFR targeted polymeric conjugates and mechanism of their internalizationPublication without faculty affiliation
- Significance of RAS testing in colorectal cancer2015 | First Faculty of Medicine
- Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- In vitro efficacy of polymeric conjugates targeted by anti-EGFR monoclonal antibody or by human polyclonal immunoglobulin IgGPublication without faculty affiliation
- Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach2022 | Publication without faculty affiliation
- Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas2012 | First Faculty of Medicine
- Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas2012 | Publication without faculty affiliation
- Efficacy of trifluridine / tipiracil in a pre-treated patient with generalized sigma cancer2019 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Rapid, deep and long lasting respnose to cetuximab2022 | Third Faculty of Medicine
- RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data2017 | Central Library of Charles University
- Hypomagnesemia in cancer patients and possible solutions2021 | Faculty of Medicine in Pilsen
- Case report: cetuximab in the 1st line of treatment of colorectal carcinoma2012 | Faculty of Medicine in Pilsen
- In vitro evaluation of concentration, labeling effectiveness and stability for I-131-labeled radioimmunoassay ligand using real-time detection technology2017 | Faculty of Pharmacy in Hradec Králové
- Localization of right/left side of colorectal carcinomas and its importance in prognosis and therapy disease2017 | Third Faculty of Medicine
- Panitumumab in treating patients with advanced metastatic colorectal cancer2012 | Faculty of Medicine in Pilsen
- Aflibercept in the treatment of metastatic colorectal cancer2014 | Second Faculty of Medicine